Niederwieser A, Matasovic A, Tippett P, Danks D M
Clin Chim Acta. 1977 May 2;76(3):345-56. doi: 10.1016/0009-8981(77)90161-9.
An unknown compound present in the urine of a girl with prolonged transient tyrosinemia and her mother was isolated and identified as (2-L-cystein-S-yl-1,4-dihydroxycyclohex-5-en-1-yl)-acetic acid (IVa). The new amino acid was named hawkinsin (Haw) and characterized by gas chromatography-mass spectrometry (GC-MS) of its penta-trimethylsilyl (TMS) derivative and of its desulfuration components. Haw was compared with the synthetic reference compound using GC-MS, IR, TLC, PC, ion-exchange chromatogrpahy and high-voltage electrophoresis. IVa and (2,6-bis-L-cystein-S-yl-1,4-dihydroxycyclohexyl-1)-acetic acid were synthesized from 4-quinolacetic acid, the latter was prepared in two different ways. It is postulated that Haw originates from an intermediate in the 4-hydroxy-phenylpuruvate hydroxylase reaction (EC 1.14.2.2), and that mother and child are heterozygous for an inborn error of metabolism characterized by a defect in this hydroxylase system, which is unable to rearrange the intermediate to homogentisic acid.
从一名患有持续性短暂性酪氨酸血症的女孩及其母亲尿液中分离出一种未知化合物,并鉴定为(2-L-半胱氨酰-S-基-1,4-二羟基环己-5-烯-1-基)-乙酸(IVa)。这种新氨基酸被命名为霍金斯酸(Haw),通过其五-三甲基硅烷基(TMS)衍生物及其脱硫成分的气相色谱-质谱联用(GC-MS)进行表征。使用GC-MS、红外光谱(IR)、薄层色谱(TLC)、纸色谱(PC)、离子交换色谱和高压电泳将Haw与合成参考化合物进行比较。IVa和(2,6-双-L-半胱氨酰-S-基-1,4-二羟基环己基-1)-乙酸由4-喹啉乙酸合成,后者通过两种不同方法制备。据推测,Haw源自4-羟基苯丙酮酸羟化酶反应(EC 1.14.2.2)中的一种中间体,并且母亲和孩子对于一种以该羟化酶系统缺陷为特征的先天性代谢错误是杂合子,该系统无法将中间体重排为尿黑酸。